Role of smooth muscle cGMP/cGKI signaling in murine vascular restenosis

Robert Lukowski, Pascal Weinmeister, Dominik Bernhard, Susanne Feil, Michael Gotthardt, Joachim Herz, Steffen Massberg, Alma Zernecke, Christian Weber, Franz Hofmann, Robert Feil

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background - Nitric oxide (NO) is of crucial importance for smooth muscle cell (SMC) function and exerts numerous, and sometimes opposing, effects on vascular restenosis. Although cGMP-dependent protein kinase type I (cGKI) is a principal effector of NO, the molecular pathway of vascular NO signaling in restenosis is unclear. The purpose of this study was to examine the functional role of the smooth muscle cGMP/cGKI signaling cascade in restenosis of vessels. Methods and Results - Tissue-specific mouse mutants were generated in which the cGKI protein was ablated in SMCs. We investigated whether the absence of cGKI in SMCs would affect vascular remodeling after carotid ligation or removal of the endothelium. No differences were detected between the tissue-specific cGKI mutants and control mice at different time points after vascular injury on a normolipidemic or apoE-deficient background. In line with these results, chronic drug treatment of injured control mice with the phosphodiesterase-5 inhibitor sildenafil elevated cGMP levels but had no influence on the ligation-induced remodeling. Conclusions - The genetic and pharmacological manipulation of the cGMP/cGKI signaling indicates that this pathway is not involved in the protective effects of NO, suggesting that NO affects vascular remodeling during restenosis via alternative mechanisms.

Original languageEnglish (US)
Pages (from-to)1244-1250
Number of pages7
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume28
Issue number7
DOIs
StatePublished - Jul 1 2008

Fingerprint

Cyclic GMP-Dependent Protein Kinase Type I
Smooth Muscle
Blood Vessels
Nitric Oxide
Ligation
Phosphodiesterase 5 Inhibitors
Vascular System Injuries
Apolipoproteins E
Smooth Muscle Myocytes
Endothelium
Pharmacology

Keywords

  • Atherosclerosis
  • Carotid ligation
  • Nitric oxide
  • PKG
  • Wire-injury

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Role of smooth muscle cGMP/cGKI signaling in murine vascular restenosis. / Lukowski, Robert; Weinmeister, Pascal; Bernhard, Dominik; Feil, Susanne; Gotthardt, Michael; Herz, Joachim; Massberg, Steffen; Zernecke, Alma; Weber, Christian; Hofmann, Franz; Feil, Robert.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 28, No. 7, 01.07.2008, p. 1244-1250.

Research output: Contribution to journalArticle

Lukowski, R, Weinmeister, P, Bernhard, D, Feil, S, Gotthardt, M, Herz, J, Massberg, S, Zernecke, A, Weber, C, Hofmann, F & Feil, R 2008, 'Role of smooth muscle cGMP/cGKI signaling in murine vascular restenosis', Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 7, pp. 1244-1250. https://doi.org/10.1161/ATVBAHA.108.166405
Lukowski, Robert ; Weinmeister, Pascal ; Bernhard, Dominik ; Feil, Susanne ; Gotthardt, Michael ; Herz, Joachim ; Massberg, Steffen ; Zernecke, Alma ; Weber, Christian ; Hofmann, Franz ; Feil, Robert. / Role of smooth muscle cGMP/cGKI signaling in murine vascular restenosis. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 2008 ; Vol. 28, No. 7. pp. 1244-1250.
@article{1f7024995cab4b4c96486bf413a968c8,
title = "Role of smooth muscle cGMP/cGKI signaling in murine vascular restenosis",
abstract = "Background - Nitric oxide (NO) is of crucial importance for smooth muscle cell (SMC) function and exerts numerous, and sometimes opposing, effects on vascular restenosis. Although cGMP-dependent protein kinase type I (cGKI) is a principal effector of NO, the molecular pathway of vascular NO signaling in restenosis is unclear. The purpose of this study was to examine the functional role of the smooth muscle cGMP/cGKI signaling cascade in restenosis of vessels. Methods and Results - Tissue-specific mouse mutants were generated in which the cGKI protein was ablated in SMCs. We investigated whether the absence of cGKI in SMCs would affect vascular remodeling after carotid ligation or removal of the endothelium. No differences were detected between the tissue-specific cGKI mutants and control mice at different time points after vascular injury on a normolipidemic or apoE-deficient background. In line with these results, chronic drug treatment of injured control mice with the phosphodiesterase-5 inhibitor sildenafil elevated cGMP levels but had no influence on the ligation-induced remodeling. Conclusions - The genetic and pharmacological manipulation of the cGMP/cGKI signaling indicates that this pathway is not involved in the protective effects of NO, suggesting that NO affects vascular remodeling during restenosis via alternative mechanisms.",
keywords = "Atherosclerosis, Carotid ligation, Nitric oxide, PKG, Wire-injury",
author = "Robert Lukowski and Pascal Weinmeister and Dominik Bernhard and Susanne Feil and Michael Gotthardt and Joachim Herz and Steffen Massberg and Alma Zernecke and Christian Weber and Franz Hofmann and Robert Feil",
year = "2008",
month = "7",
day = "1",
doi = "10.1161/ATVBAHA.108.166405",
language = "English (US)",
volume = "28",
pages = "1244--1250",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Role of smooth muscle cGMP/cGKI signaling in murine vascular restenosis

AU - Lukowski, Robert

AU - Weinmeister, Pascal

AU - Bernhard, Dominik

AU - Feil, Susanne

AU - Gotthardt, Michael

AU - Herz, Joachim

AU - Massberg, Steffen

AU - Zernecke, Alma

AU - Weber, Christian

AU - Hofmann, Franz

AU - Feil, Robert

PY - 2008/7/1

Y1 - 2008/7/1

N2 - Background - Nitric oxide (NO) is of crucial importance for smooth muscle cell (SMC) function and exerts numerous, and sometimes opposing, effects on vascular restenosis. Although cGMP-dependent protein kinase type I (cGKI) is a principal effector of NO, the molecular pathway of vascular NO signaling in restenosis is unclear. The purpose of this study was to examine the functional role of the smooth muscle cGMP/cGKI signaling cascade in restenosis of vessels. Methods and Results - Tissue-specific mouse mutants were generated in which the cGKI protein was ablated in SMCs. We investigated whether the absence of cGKI in SMCs would affect vascular remodeling after carotid ligation or removal of the endothelium. No differences were detected between the tissue-specific cGKI mutants and control mice at different time points after vascular injury on a normolipidemic or apoE-deficient background. In line with these results, chronic drug treatment of injured control mice with the phosphodiesterase-5 inhibitor sildenafil elevated cGMP levels but had no influence on the ligation-induced remodeling. Conclusions - The genetic and pharmacological manipulation of the cGMP/cGKI signaling indicates that this pathway is not involved in the protective effects of NO, suggesting that NO affects vascular remodeling during restenosis via alternative mechanisms.

AB - Background - Nitric oxide (NO) is of crucial importance for smooth muscle cell (SMC) function and exerts numerous, and sometimes opposing, effects on vascular restenosis. Although cGMP-dependent protein kinase type I (cGKI) is a principal effector of NO, the molecular pathway of vascular NO signaling in restenosis is unclear. The purpose of this study was to examine the functional role of the smooth muscle cGMP/cGKI signaling cascade in restenosis of vessels. Methods and Results - Tissue-specific mouse mutants were generated in which the cGKI protein was ablated in SMCs. We investigated whether the absence of cGKI in SMCs would affect vascular remodeling after carotid ligation or removal of the endothelium. No differences were detected between the tissue-specific cGKI mutants and control mice at different time points after vascular injury on a normolipidemic or apoE-deficient background. In line with these results, chronic drug treatment of injured control mice with the phosphodiesterase-5 inhibitor sildenafil elevated cGMP levels but had no influence on the ligation-induced remodeling. Conclusions - The genetic and pharmacological manipulation of the cGMP/cGKI signaling indicates that this pathway is not involved in the protective effects of NO, suggesting that NO affects vascular remodeling during restenosis via alternative mechanisms.

KW - Atherosclerosis

KW - Carotid ligation

KW - Nitric oxide

KW - PKG

KW - Wire-injury

UR - http://www.scopus.com/inward/record.url?scp=46249094707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46249094707&partnerID=8YFLogxK

U2 - 10.1161/ATVBAHA.108.166405

DO - 10.1161/ATVBAHA.108.166405

M3 - Article

VL - 28

SP - 1244

EP - 1250

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 7

ER -